2025 Flashcards
(100 cards)
This alkylating agent is administered orally to treat chronic granulocytic leukemia and other myeloproliferative disorders. In high doses, it produces a rare but sometimes fatal pulmonary fibrosis.
A) Bleomycin
B) Busulfan
C) Cisplatin
D) Cyclophosphamide
B) Busulfan
High-Yield Rationale:
* Busulfan is an alkylating agent specifically used in chronic myeloid leukemia (CML) and other myeloproliferative disorders.
* It is administered orally.
* High-dose Busulfan is associated with pulmonary fibrosis (also called “Busulfan lung”), which can be fatal.
Why other options are incorrect:
* A) Bleomycin: Also causes pulmonary fibrosis, but it is not an alkylating agent, and is used for testicular cancer and Hodgkin lymphoma.
* C) Cisplatin: Alkylating-like but causes nephrotoxicity, ototoxicity, and peripheral neuropathy, not pulmonary fibrosis.
* D) Cyclophosphamide: Alkylating agent used in many cancers and autoimmune conditions, but main toxicity is hemorrhagic cystitis, not pulmonary fibrosis.
This drug is a potent immunosuppressant. It is used in the management of rheumatoid disorders and autoimmune nephritis. It attacks the N7 of guanine and can cause hemorrhagic cystitis.
A) Daunorubicin
B) Doxorubicin
C) Cyclophosphamide
D) Carmustine
This pyrimidine antimetabolite is bioactivated to inhibit thymidylate synthetase and is used topically for basal cell carcinoma.
A) 6-MP
B) 6-TG
C) Vincristine
D) 5-FU
This substance is used to trap acrolein and protects the bladder during cyclophosphamide therapy.
A) Leucovorin
B) Amifostine
C) Mesna
D) Dexrazoxane
Which of the following drugs is specific to the M phase?
A) Bleomycin
B) Paclitaxel
C) Cisplatin
D) Etoposide
These drugs are also called anthracyclines.
A) Thiotepa, busulfan, nitrosoureas
B) Cisplatin, carboplatin, oxaliplatin
C) Doxorubicin, daunorubicin
D) Procarbazine, dacarbazine
C) Doxorubicin, daunorubicin
High-Yield Rationale:
* Anthracyclines are antitumor antibiotics derived from Streptomyces.
* Includes doxorubicin and daunorubicin.
* MOA: Intercalate into DNA, inhibit topoisomerase Il, and generate free radicals → cardiotoxicity is a major side effect.
Why other options are incorrect:
* A) Thiotepa, busulfan, nitrosoureas: Alkylating agents, not anthracyclines.
* B) Cisplatin, carboplatin, oxaliplatin: Platinum compounds, alkylating-like agents.
* D) Procarbazine, dacarbazine: Methylating/alkylating agents, used in Hodgkin lymphoma and brain tumors; not anthracyclines.
These compounds were known as the nitrogen mustard gases that were observed to inhibit cell growth, especially of bone marrow shortly after the war.
A) Alkylating agents
B) Antimetabolites
C) Monoclonal antibodies
D) Platinum complexes
A) Alkylating agents
High-Yield Rationale:
* Alkylating agents, including nitrogen mustards (e.g., mechlorethamine), were among the first chemotherapy agents.
* Observed after WWI/WWII when mustard gas exposure caused bone marrow suppression, leading to their development as anticancer drugs.
* MOA: Cross-link DNA → inhibit replication and lead to apoptosis, especially in rapidly dividing cells (e.g., bone marrow, GI tract).
Why other options are incorrect:
* B) Antimetabolites: Interfere with DNA/RNA synthesis (e.g., methotrexate, 5-FU), but not derived from mustard gas.
* C) Monoclonal antibodies: Target specific cell markers; not related to early chemotherapy or nitrogen mustards.
* D) Platinum complexes: Alkylating-like agents (e.g., cisplatin), not mustard derivatives.
This drug can cause severe hypoglycemia within 3 hours of administration to type 1 DM patients.
A) Miglitol
B) Pramlintide
C) Insulin
D) Gliclazide
This drug slows intestinal carbohydrate digestion and absorption, which requires a frequent dosing schedule. ADRs include flatulence and hepatotoxicity.
A) Metformin
B) Acarbose
C) Nateglinide
D) Exenatide
Exenatide is contraindicated in Annabelle because of which of the following findings?
A) Creatinine clearance of 25 ml/min
B) History of leukemia
C) Lymphocyte count of 7%
D) HbA1c of 8%
Who among the following patients cannot take Metformin?
A) Mario, 57/M, Serum creatinine of 1.2 mg/dL
B) Elsie, 16/F, 102kg, Serum creatinine of 1.8 mg/dL
C) Martha, 78/F, Serum creatinine of 1.4 mg/dL
D) Lawrence, 65/M, hypertensive metastatic lung cancer patient
Which of the following is the most potent sulfonylurea?
A) Tolbutamide
B) Chlorpropamide
C) Glyburide
D) Tolazamide
: C) Glyburide
High-Yield Rationale:
Glyburide (glibenclamide) is a 2nd-generation sulfonylurea, which are significantly more potent than 1st-gen agents.
Requires lower doses for effect but has a higher risk of hypoglycemia, especially in elderly and renal impairment.
Which of the following has the highest risk of hypoglycemia?
A) Tolbutamide
B) Chlorpropamide
C) Glyburide
D) Tolazamide
Which of the following is the drug to treat diabetes insipidus?
A) Tolbutamide
B) Chlorpropamide
C) Glyburide
D) Tolazamide
Cynthia, 85/F, has contraindications for Metformin. Dr. Sy instructed you to give her the most appropriate sulfonylurea. Which of the following is your preferred agent?
A) Glipizide
B) Glimepiride
C) Chlorpropamide
D) Tolbutamide
Jennifer had renal impairment and metformin was contraindicated. What will be the best alternative hypoglycemic drug for her?
A) Glipizide
B) Glimepiride
C) Chlorpropamide
D) Tolbutamide
Pia is a known case of hyperthyroidism. She got married and is currently on her 8th week of pregnancy. Which of the following is the safest drug for her?
A) Methimazole
B) Carbimazole
C) PTU
D) Iodine 131
C) PTU (Propylthiouracil)
High-Yield Rationale:
* PTU is the preferred drug for hyperthyroidism during the first trimester of pregnancy.
* It inhibits both thyroid peroxidase and peripheral T4 → T3 conversion.
* After the first trimester, therapy is usually shifted to methimazole to avoid PTU hepatotoxicity.
Why the others are incorrect:
* A) Methimazole: Teratogenic in 1st trimester (risk of aplasia cutis, choanal/esophageal atresia).
* B) Carbimazole: Prodrug of methimazole; same teratogenic risks in early pregnancy.
* D) lodine 131: Absolutely contraindicated in pregnancy due to its radioactive effect on the fetal thyroid.
Which of the following will displace thyroid hormone from protein binding?
A) Rifampin
B) Colestipol
C) Furosemide
D) Lithium
Which of the following is a 5HT antagonist antidepressant?
A) Sertraline
B) Trazodone
C) Mirtazepine
D) Selegiline
B) Trazodone
High-Yield Rationale:
Trazodone is a serotonin antagonist and reuptake inhibitor (SARI).
It blocks 5-HT2A receptors and weakly inhibits serotonin reuptake.
Also used for insomnia due to its sedating effects.
Main adverse effect: priapism (persistent painful erection).
Why the others are incorrect:
A) Sertraline: SSRI (selective serotonin reuptake inhibitor), not a 5-HT antagonist.
C) Mirtazapine: Noradrenergic and specific serotonergic antidepressant (NaSSA); antagonizes α2 and 5-HT2/5-HT3, but it’s not classified as a 5-HT antagonist antidepressant like Trazodone.
D) Selegiline: MAO-B inhibitor used in Parkinson’s; not an antidepressant with 5-HT antagonism.
This drug is used for Bipolar Disorder that decreases cAMP and inhibits inositol 1 triphosphate.
A) Amoxapine
B) Bupropion
C) Clomipramine
D) Lithium
Lyndon was found unconscious in his room. He was brought to the ER and found to have cardiotoxicity and convulsions. The EM team suspects overdose. Which of the following could be the drug?
A) Fluoxetine
B) Duloxetine
C) Amitriptyline
D) Selegiline
C) Amitriptyline
High-Yield Rationale:
Amitriptyline is a tricyclic antidepressant (TCA).
TCA overdose → cardiotoxicity (due to Na⁺ channel blockade), CNS toxicity (seizures, coma), and anticholinergic effects.
EKG: Prolonged QRS/QT, ventricular arrhythmias.
Antidote: Sodium bicarbonate.
Why the others are incorrect:
A) Fluoxetine: SSRI; overdose rarely causes cardiotoxicity or seizures.
B) Duloxetine: SNRI; may cause serotonin syndrome but less cardiotoxicity.
D) Selegiline: MAO-B inhibitor; overdose might cause hypertensive crisis, not typically seizures or cardiotoxicity.
Which of the following is the drug used for serotonin syndrome?
A) Cyproheptadine
B) Benzodiazepine
C) Lamotrigine
D) Paroxetine
This drug inhibits neuronal reuptake of serotonin and norepinephrine and is used to treat major depressive disorder and neuropathic pain.
A) Phenelzine
B) Nefazodone
C) Venlafaxine
D) Imipramine
C) Venlafaxine
High-Yield Rationale:
Venlafaxine is a serotonin-norepinephrine reuptake inhibitor (SNRI).
Effective in major depressive disorder, generalized anxiety, and neuropathic pain (e.g., diabetic neuropathy, fibromyalgia).
Why the others are incorrect:
A) Phenelzine: MAOI; not first-line due to hypertensive crisis risk.
B) Nefazodone: Weak 5-HT/NE reuptake inhibitor; rarely used due to hepatotoxicity.
D) Imipramine: TCA; blocks reuptake of NE and 5-HT but not classified as SNRI, and more side effects (anticholinergic, cardiotoxic).
This is a tetracyclic antidepressant that increases amine release from nerve endings by antagonism of presynaptic α2 adrenoreceptors. It also blocks serotonin 5HT2 receptors.
A) Mirtazapine
B) Duloxetine
C) Lithium
D) Alprazolam
A) Mirtazapine
High-Yield Rationale:
Mirtazapine is a tetracyclic antidepressant.
MOA: α2 antagonist → increases NE and 5-HT release; also blocks 5-HT2 and 5-HT3 receptors.
Good for patients with depression and insomnia or weight loss, as it increases appetite and causes sedation.
Why the others are incorrect:
B) Duloxetine: SNRI; does not affect α2 receptors.
C) Lithium: Mood stabilizer; not an antidepressant and doesn’t block 5-HT2 or α2.
D) Alprazolam: Benzodiazepine (anxiolytic); not an antidepressant.